[ET Net News Agency, 30 September 2026] GENSCRIPT BIO (01548) rose 10.1% to HK$45.6.
It hits an intra-day high of HK$45.6, hitting a historical high, and an intra-day low of HK$41. The total shares traded was 15 million, with a value of HK$665.81m. The active buy/sell ratio is 67:33, with net buying turnover of HK$216.76m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$15.98m, with volume weighted average price of HK$44.057. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$40.72m, with volume weighted average price of HK$44.301.
Basic Information| Nominal | 45.600 | % Chg | +10.14% |
| High | 45.600 | Low | 41.000 |
| Shares Tr | 15m | Turnover | 665.81m |
| 10-D SMA | 41.186 | %H.V | 99.097 |
| 20-D SMA | 37.114 | VWAP | 44.373 |
| 50-D SMA | 30.244 | RSI14 | 70.019 |
Status: Hitting a historical high, active buy/sell ratio is 67:33, with net buying turnover of HK$216.76m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| GENSCRIPT BIO (01548) | 45.600 | +10.14 |
| INNOVENT BIO (01801) | 97.050 | +1.20 |
| EVEREST MED (01952) | 29.480 | +5.36 |
| XTALPI (02228) | 8.205 | +3.99 |
| WUXI XDC (02268) | 80.750 | +3.46 |
| WUXI BIO (02269) | 55.050 | +2.90 |
| WUXI APPTEC (02359) | 211.600 | +1.83 |
| BEONE MEDICINES (06160) | 223.000 | +2.39 |
| CANSINOBIO (06185) | 36.280 | +16.66 |
| AKESO (09926) | 106.000 | -0.28 |
(ed)